← 返回

整合单细胞和空间转录组分析以揭示高级别浆液性卵巢癌的异质性

英文原题:Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer.

查看英文原题

Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer.

PubMed 2024/06/21(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

高级别浆液性卵巢癌(HGSOC)因其异质性和晚期诊断而带来重大挑战。利用单细胞和空间转录组学阐明HGSOC的复杂景观,以理解其潜在机制。

我们的分析揭示了显著的肿瘤间和肿瘤内多样性,表现为不同的细胞亚群和多样的微环境生态位。值得注意的是,我们的发现强调了一个广泛的免疫抑制环境,以复杂的细胞间相互作用网络为标志,在转移样本中肿瘤细胞密度升高的区域尤为明显。

我们鉴定出COL14A1+肿瘤细胞仅存在于转移标本中,同时发现CD8A+ NKT细胞与不良预后之间存在强相关性,以及HGSOC转移组织中CHODL表达升高。

此外,针对CHODL的敲低实验证明其在降低HGSOC细胞迁移和侵袭能力中的作用。我们研究的一个关键发现是描绘了与不良结局相关的特定细胞特征,特别是一组CHODL+肿瘤细胞亚群,其特征为具有独特代谢表型并倾向于脂质代谢。使用现有抑制剂靶向该代谢通路在抑制肿瘤增殖方面似乎具有前景。这些发现增强了我们对HGSOC异质性的理解,并揭示了潜在的治疗靶点,有望为这一侵袭性癌症亚型提供更有效的管理策略。

展开英文摘要原文

High-grade serous ovarian cancer (HGSOC) presents significant challenges due to its heterogeneity and late-stage diagnoses. Using single-cell and spatial transcriptomics to elucidate the complex landscape of HGSOC to understand its underlying mechanism.

Our analysis reveals significant inter- and intra-tumoral diversity, manifested through distinct cellular subpopulations and varied microenvironmental niches.

Notably, our findings highlight a widespread immunosuppressive environment, marked by complex networks of cell-cell interactions, particularly evident in areas of elevated tumor cell density within metastatic samples.

We identify the exclusive presence of COL14A1+ neoplastic cells in metastatic specimens, alongside a strong correlation between CD8A+ NKT cells and poor prognosis, and elevated CHODL expression in HGSOC metastasis tissues.

Furthermore, knockdown experiments targeting CHODL demonstrate its role in reducing migration and invasion abilities in HGSOC cells. A pivotal discovery of our study is the delineation of specific cellular signatures correlated with adverse outcomes, notably a subset of CHODL+ neoplastic cells characterized by a distinct metabolic phenotype with a predilection for lipid metabolism. The therapeutic targeting of this metabolic pathway with existing inhibitors appears promising in curbing tumor proliferation.

These findings enhance our understanding of HGSOC heterogeneity and reveal potential therapeutic targets, promising more effective management strategies for this aggressive cancer subtype.

论文信息

作者
Luo H、Wang K、Li B
单位
Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.China
文献类型
非美国政府资助研究
期刊
Frontiers in immunology2024
原文标识
PubMed 38975339 · DOI 10.3389/fimmu.2024.1420847